China SXT Pharmaceuticals (SXTC) announced that the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market dated March 13, 2025, informing the Company that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2) and the matter is closed.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SXTC:
Questions or Comments about the article? Write to editor@tipranks.com